4.09
前日終値:
$4.21
開ける:
$4.22
24時間の取引高:
1.87M
Relative Volume:
0.55
時価総額:
$550.09M
収益:
-
当期純損益:
$-217.44M
株価収益率:
-1.8848
EPS:
-2.17
ネットキャッシュフロー:
$-205.20M
1週間 パフォーマンス:
-10.50%
1か月 パフォーマンス:
+69.01%
6か月 パフォーマンス:
+44.52%
1年 パフォーマンス:
-27.09%
Prime Medicine Inc Stock (PRME) Company Profile
PRME を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
PRME
Prime Medicine Inc
|
4.09 | 566.23M | 0 | -217.44M | -205.20M | -2.17 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Prime Medicine Inc Stock (PRME) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-05-27 | ダウングレード | Citigroup | Buy → Neutral |
2025-05-20 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2025-05-20 | ダウングレード | JP Morgan | Overweight → Neutral |
2024-12-10 | 開始されました | JMP Securities | Mkt Outperform |
2024-05-20 | 開始されました | H.C. Wainwright | Buy |
2024-05-16 | アップグレード | Citigroup | Neutral → Buy |
2024-04-22 | 開始されました | Chardan Capital Markets | Buy |
2024-04-08 | 開始されました | TD Cowen | Buy |
2024-04-03 | 開始されました | Wedbush | Outperform |
2024-01-16 | ダウングレード | Stifel | Buy → Hold |
2023-12-08 | 開始されました | Citigroup | Neutral |
2023-10-09 | 開始されました | BMO Capital Markets | Outperform |
2023-07-31 | 開始されました | Guggenheim | Buy |
2023-04-18 | 開始されました | Stifel | Buy |
2022-11-14 | 開始されました | Goldman | Neutral |
2022-11-14 | 開始されました | JP Morgan | Overweight |
2022-11-14 | 開始されました | Jefferies | Buy |
2022-11-14 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Prime Medicine Inc (PRME) 最新ニュース
Prime Medicine’s SWOT analysis: gene editing firm faces cash crunch amid strategic shift - Investing.com
Intraday Charts Show Spike in Prime Medicine Inc. ActivityShort Term High Yield Stock Tips for Active Traders - metal.it
What are the technical indicators suggesting about Prime Medicine Inc.Free Stock Trend Scanner That Work - jammulinksnews.com
What is Prime Medicine Inc. company’s growth strategyConsistent double returns - jammulinksnews.com
When is Prime Medicine Inc. stock expected to show significant growthBreakthrough investment results - jammulinksnews.com
What are Prime Medicine Inc. company’s key revenue driversHigh-impact stock picks - jammulinksnews.com
What is the risk reward ratio of investing in Prime Medicine Inc. stockOutperformance with explosive growth - jammulinksnews.com
What institutional investors are buying Prime Medicine Inc. stockAchieve consistent profits with smart trading - jammulinksnews.com
Does Prime Medicine Inc. stock perform well during market downturnsExplosive earnings growth - jammulinksnews.com
What are the latest earnings results for Prime Medicine Inc.Get high-impact stock recommendations now - jammulinksnews.com
What makes Prime Medicine Inc. stock price move sharplyFree Real-Time Trading Opportunities - metal.it
How Prime Medicine Inc. stock performs during market volatilitySmart Return Focused Trading - metal.it
What drives Prime Medicine Inc. stock priceUnmatched market performance - PrintWeekIndia
Is Prime Medicine Inc. a good long term investmentFree Capital Growth Strategies - Autocar Professional
Is Prime Medicine Inc. stock a good hedge against inflationFree Risk Assessment Services - jammulinksnews.com
What analysts say about Prime Medicine Inc. stockAccelerated investment success - Autocar Professional
Prime Medicine Inc. Stock Analysis and ForecastSkyrocketing profit margins - jammulinksnews.com
Prime Medicine(PRME) Shares Soar 10.65% on Analyst Rating, Funding Boost - AInvest
Prime Medicine Surges 18% on Funding Catalyst: Is This the Start of a Biotech Breakout? - AInvest
BMO Capital Maintains a Buy on Prime Medicine (PRME), Sets a $10 PT - MSN
Prime Medicine stock price target reiterated at $6 by JMP on CF funding - Investing.com Canada
Prime Medicine (PRME.O) Surges 5.9%: What’s Behind the Intraday Rally? - AInvest
Prime Medicine (PRME): A High-Conviction Biotech Play with a 154% Upside - AInvest
10 Hot Penny Stocks to Invest in Now - Insider Monkey
Prime Medicine Inc (PRME) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):